Search results
Results from the WOW.Com Content Network
In April 2017, Neuralink announced that it was aiming to make devices to treat serious brain diseases in the short term, with the eventual goal of human enhancement, sometimes called transhumanism. [ 22 ] [ 10 ] [ 23 ] Musk said his interest in the idea partly stemmed from the concept of " neural lace " in the fictional universe in The Culture ...
Elon Reeve Musk (/ ˈ iː l ɒ n m ʌ s k /; born June 28, 1971) is a businessman known for his key roles in the space company SpaceX and the automotive company Tesla, Inc. He is also known for his ownership of X Corp. (the company that operates the social media platform X, formerly Twitter), and his role in the founding of the Boring Company, xAI, Neuralink, and OpenAI.
Neuralink, which first tested its device in monkeys and other animals, is now testing the device in humans. The company makes a brain-chip which enables paralyzed patients to control a computer ...
To help run Neuralink Musk called in the help of Shivon Zilis, who previously worked at Tesla, and was a director at OpenAI, which he co founded but no longer owns. Musk and Zilis are close, so ...
According to Elon Musk, the first human received an implant from his computer-brain interface company Neuralink over the weekend. In a Monday post on X, the platform formerly known as Twitter ...
An mRNA vaccine is a type of vaccine that uses a copy of a molecule called messenger RNA (mRNA) to produce an immune response. [1] The vaccine delivers molecules of antigen -encoding mRNA into cells , which use the designed mRNA as a blueprint to build foreign protein that would normally be produced by a pathogen (such as a virus ) or by a ...
Neuralink was formed in 2016, in the hope of creating a new way for humans to interface with machines. Mr Musk has suggested it could offer a way for people to integrate virtual reality with their ...
A nucleoside-modified messenger RNA (modRNA) is a synthetic messenger RNA (mRNA) in which some nucleosides are replaced by other naturally modified nucleosides or by synthetic nucleoside analogues.